Patents by Inventor Susan R. Rittling

Susan R. Rittling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS
    Publication number: 20150344534
    Abstract: The present invention relates to pharmaceutical compositions and nutritional supplements comprising an osteopontin variant, and medical use of such compositions and supplements for treating or preventing tumor-generating cancer.
    Type: Application
    Filed: December 7, 2012
    Publication date: December 3, 2015
    Inventors: SUSAN R RITTLING, PETER LANGBORG WEJSE, ANJA SERENA
  • OSTEOPONTIN PEPTIDE FRAGMENTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH
    Publication number: 20150190460
    Abstract: The present invention relates to isolated, pharmaceutically active, osteopontin-related molecules, pharmaceutical compositions and nutritional supplements comprising such molecules, and use of such compositions and supplements for treating or preventing tumor-generating cancer.
    Type: Application
    Filed: July 19, 2013
    Publication date: July 9, 2015
    Inventors: Susan R. Rittling, Peter Langborg Wejse, Anja Serena
  • Osteopontin knock-out mouse and methods of use thereof
    Publication number: 20020188962
    Abstract: A transgenic non-human animal with alterations in the osteopontin gene is prepared by introduction of a gene encoding an altered osteopontin protein into a host non-human animal. Methods for using transgenic mice so generated to screen for agents that effect osteopontin's cellular modulating activity are also provided.
    Type: Application
    Filed: July 2, 2002
    Publication date: December 12, 2002
    Inventors: David T. Denhardt, Susan R. Rittling, Masaki Noda, Aaron J. Kowalski
  • Osteopontin knock-out mouse and methods of use thereof
    Patent number: 6414219
    Abstract: A transgenic non-human animal with alterations in the osteopontin gene is prepared by introduction of a gene encoding an altered osteopontin protein into a host non-human animal. Methods for using transgenic mice so generated to screen for agents that effect osteopontin's cellular modulating activity are also provided.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: July 2, 2002
    Assignee: Rutgers, The State University of New Jersey
    Inventors: David T. Denhardt, Susan R. Rittling, Masaki Noda, Aaron J. Kowalski